NDC 0469-2602 – Myrbetriq

Mirabegron 50 mg/1 · Tablet, Film Coated, Extended Release · Oral

Human Prescription Drug

Product NDC0469-2602

Product details

Brand name
Myrbetriq
Generic name
Mirabegron
Labeler
Astellas Pharma US, Inc.
Dosage form
Tablet, Film Coated, Extended Release
Route
Oral
Marketing category
NDA · NDA202611
Marketed since
June 28, 2012
Listing expires
December 31, 2026
Pharmacologic class
beta3-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Myrbetriq →

Package NDC codes (3)

Package NDCDescriptionSince
0469-2602-07 sample4 CARTON in 1 TRAY (0469-2602-07) / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKJun 28, 2012
0469-2602-301 BOTTLE in 1 CARTON (0469-2602-30) / 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLEJun 28, 2012
0469-2602-901 BOTTLE in 1 CARTON (0469-2602-90) / 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLEJun 28, 2012

Other Myrbetriq products